🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆
Clinical Trials in Canada / NCT05721261
Recruiting Not applicable

Regeneration of Acutely Injured Nerves With Temporary Electrical Stimulation

NCT05721261 · tracked via the Priya Life Science Canada tracker
Sponsor
Epineuron Technologies Inc
Phase
Not applicable
Started
2023-08-11
Last updated
2026-03-16

Condition(s) studied

Nerve Injury

Investigational drug(s) / intervention(s)

Temporary Peripheral Nerve Stimulation SystemSham Temporary Peripheral Nerve Stimulation System

Temporary Peripheral Nerve Stimulation System: Single use medical device. Therapy consists of single, 1 hour dose of electrical stimulation delivered proximal to injury site.

Sham Temporary Peripheral Nerve Stimulation System: Single use medical device. Sham treatment consists of single, 1 hour dose of sham stimulation.

Study summary

A novel temporary peripheral nerve stimulation system that delivers a single dose of electrical stimulation therapy for 1 hour will be evaluated for safety and effectiveness.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion criteria: * Peripheral nerve injury Exclusion criteria: * Peripheral neuropathy * Patients with any active implanted device

Primary outcome measure(s)

Trial sites (15)

FacilityCityRegionStatus
University of Florida Health Gainesville Florida Recruiting
Orlando Health Jewett Orthopedic Institute Orlando Florida Recruiting
Louisiana State University Health Sciences Center New Orleans Louisiana Recruiting
The Curtis National Hand Center Baltimore Maryland Completed
WellSpan Health York Pennsylvania Completed
John Peter Smith Hospital Fort Worth Texas Recruiting
University of Alberta Hospital Edmonton Alberta Completed
Saint John Regional Hospital Saint John New Brunswick Recruiting
Hamilton General Hospital Hamilton Ontario Recruiting
St. Joseph's Healthcare Hamilton Hamilton Ontario Recruiting
Roth | McFarlane Hand & Upper Limb Centre London Ontario Active Not Recruiting
Southlake Health Newmarket Ontario Recruiting
Humber River Health Toronto Ontario Recruiting
North York General Hospital Toronto Ontario Recruiting
Trillium Health Partners Toronto Ontario Recruiting

More Epineuron Technologies Inc. trials in Canada

Short Duration Electrical Stimulation to Improve Outcomes After Cubital Tunnel Release (SELECT) Trial Recruiting

Other trials for the same condition

Assessing Spinal Accessory Nerve Recovery After Post-operative Electrical Stimulation Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05721261 on ClinicalTrials.gov ↗ ← All trials in Canada